Omzo vs Regenics: Compounded Semaglutide Plans Compared
Quick verdict: For clinician-reviewed compounded medication with an option to receive prescriptions for branded GLP-1s, Omzo emphasizes licensed U.S. provider oversight and starts at $179. For lower promotional entry pricing and nurse-practitioner-led telehealth with a LegitScript certified pharmacy network and a Sermorelin option, Regenics starts at $139 the first month and renews at $199 for semaglutide.
Explore Omzo clinician-guided plans
How Omzo vs Regenics differ on price and renewal terms
Both providers offer compounded semaglutide and tirzepatide, but pricing structures differ. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. Regenics promotes semaglutide at $139 for the first month with a renewal price of $199, and tirzepatide at $189 first month with a renewal of $279.
See Regenics first month pricing
Clinician oversight and care model comparison
Omzo connects users with licensed U.S. providers who review plans and determine medication eligibility. The platform notes clinical services are provided by third party networks of licensed clinicians who make final prescribing decisions. Regenics delivers nurse-practitioner-led GLP-1 care where licensed nurse practitioners review intake before any prescription and oversee every prescription.
Medication sourcing, regulatory notices, and pharmacy details
Both Omzo and Regenics offer compounded medications prepared by U.S. compounding pharmacies. Each provider includes the regulatory note that compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness, or quality. Regenics additionally highlights a LegitScript certified pharmacy network and free shipping when medication is compounded in the USA. Omzo states compounded medications are produced in FDA registered facilities but are not FDA approved, and also notes providers may write prescriptions for branded medications that Omzo does not sell or ship.
Additional services and features that set them apart
Regenics lists Sermorelin peptide therapy as an available add on for recovery, energy, and muscle support and emphasizes free shipping and no insurance required to start. Omzo highlights clinician-guided plans reviewed by licensed U.S. providers, offers both compounded medication programs and the option for providers to prescribe branded GLP-1s which patients must fill at their chosen pharmacy, and mentions FSA and HSA eligibility.
Direct comparison table
| Criteria | Omzo | Regenics |
|---|---|---|
| Starting semaglutide price | $179 starting | $139 first month, renews $199 |
| Clinician oversight | Licensed U.S. providers review plans | Licensed nurse practitioners review intake |
| Compounded medication note | Compounded meds prepared by state licensed sterile compounding pharmacy; not FDA approved | Compounded meds from U.S. pharmacies; not FDA approved |
| Pharmacy certification and shipping | Produced in FDA registered facilities; fast, discreet delivery noted | LegitScript certified pharmacy network; free shipping for compounded meds in USA |
| Branded prescription option | Providers may write prescriptions for branded meds; Omzo does not sell or ship branded meds | No branded prescription option specified in captured evidence |
| Additional therapies | No additional peptide line noted | Offers Sermorelin peptide therapy |
What the evidence does not supply
The captured sources do not provide direct comparative clinical outcomes, guarantees of weight loss, detailed cancellation policies, or full state-by-state availability beyond the supplier notes. Do not assume efficacy or availability beyond what each source states. Both note that eligibility and prescription decisions are subject to clinician review.
Final take on Omzo vs Regenics
Omzo is built around clinician-guided plans with compounded medication programs and an explicit pathway for providers to prescribe branded GLP-1s that patients must fill elsewhere. Regenics positions itself with lower promotional entry pricing for the first month, nurse-practitioner-led telehealth, a LegitScript certified pharmacy network, free shipping for compounded meds, and an offered Sermorelin peptide option. Both emphasize that compounded medications are not FDA approved and that clinicians determine medical appropriateness.
Choose Omzo if…
you want clinician-guided plans reviewed by licensed U.S. providers, access to a compounded medication program plus the option for a provider to write a prescription for branded GLP-1s, and you accept that compounded drugs are not FDA approved.
Choose Regenics if…
you prefer a lower promotional first month price for semaglutide, nurse-practitioner-led telehealth care, a LegitScript certified pharmacy network with free shipping for compounded medications, or access to Sermorelin peptide therapy. Both services require clinician review to determine medical appropriateness.